Aforé by Dr. Few has launched a new CR Emulsion clinically tested facial cream. The cream use CBD, retinol, and a blend of peptides to reduce wrinkles, fine lines, hyperpigmentation, and other signs of aging. In a clinical study led by Dr. Few, adding CBD, a naturally anti-inflammatory ingredient, to the base 0.2% retinol solution, maintains the anti-aging properties, but with reduced side effects. The study found a significant reduction in both static and dynamic wrinkles, fine lines, hyperpigmentation, and pore size in all of patients who used the CR Emulsion, with no patients reporting significant irritation during the six week trial. "CBD alone has shown immense promise in cosmetic medicine, when it's incorporated properly and with synergistic ingredients," says Dr. Julius Few, the line’s founder. "CBD is anti-inflammatory and pro-healing in nature. I believe that the anti-inflammatory and antioxidant CBD properties are an essential component of protecting the skin and contribute to the graceful aging of any skin type."
Related Articles
Aforé by Dr. Few Unveils Physician-Formulated CBD Mist
Oliveda Releases New CBD Beauty Line